LANTERN PHARMA INC's ticker is LTRN and the CUSIP is 51654W101. A total of 22 filers reported holding LANTERN PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,318 | -39.5% | 4,492 | +0.1% | 0.00% | – |
| Q2 2023 | $25,312 | +16.8% | 4,488 | +0.0% | 0.00% | – |
| Q1 2023 | $21,667 | -10.0% | 4,486 | +12.6% | 0.00% | – |
| Q4 2022 | $24,070 | +26.7% | 3,985 | +0.0% | 0.00% | – |
| Q3 2022 | $19,000 | -9.5% | 3,984 | +5.4% | 0.00% | – |
| Q2 2022 | $21,000 | -16.0% | 3,780 | +6.2% | 0.00% | – |
| Q1 2022 | $25,000 | +177.8% | 3,558 | +188.8% | 0.00% | – |
| Q4 2021 | $9,000 | -18.2% | 1,232 | +29.3% | 0.00% | – |
| Q3 2021 | $11,000 | -89.9% | 953 | -87.2% | 0.00% | – |
| Q2 2021 | $109,000 | +65.2% | 7,423 | +103.8% | 0.00% | – |
| Q1 2021 | $66,000 | +6500.0% | 3,643 | +5257.4% | 0.00% | – |
| Q4 2020 | $1,000 | – | 68 | +518.2% | 0.00% | – |
| Q3 2020 | $0 | – | 11 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SANDERS MORRIS HARRIS LLC | 365,930 | $1,721,000 | 0.42% |
| CM Management, LLC | 50,000 | $239,000 | 0.27% |
| WOLFF WIESE MAGANA LLC | 30,462 | $146,000 | 0.12% |
| Redmond Asset Management, LLC | 49,502 | $237,000 | 0.09% |
| CARLSON CAPITAL L P | 168,000 | $803,000 | 0.06% |
| NewEdge Advisors, LLC | 171,019 | $817,000 | 0.01% |
| Sigma Planning Corp | 17,500 | $84,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 3,984 | $19,000 | 0.00% |
| NORTHERN TRUST CORP | 12,629 | $60,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |